Document Detail

The 2011 canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.
MedLine Citation:
PMID:  21801975     Owner:  NLM     Status:  In-Data-Review    
We updated the evidence-based recommendations for the diagnosis, assessment, prevention, and treatment of hypertension in adults for 2011. The major guideline changes this year are: (1) a recommendation was made for using comparative risk analogies when communicating a patient's cardiovascular risk; (2) diagnostic testing issues for renal artery stenosis were discussed; (3) recommendations were added for the management of hypertension during the acute phase of stroke; (4) people with hypertension and diabetes are now considered high risk for cardiovascular events if they have elevated urinary albumin excretion, overt kidney disease, cardiovascular disease, or the presence of other cardiovascular risk factors; (5) the combination of an angiotensin-converting enzyme (ACE) inhibitor and a dihydropyridine calcium channel blocker (CCB) is preferred over the combination of an ACE inhibitor and a thiazide diuretic in persons with diabetes and hypertension; and (6) a recommendation was made to coordinate with pharmacists to improve antihypertensive medication adherence. We also discussed the recent analyses that examined the association between angiotensin II receptor blockers (ARBs) and cancer.
Doreen M Rabi; Stella S Daskalopoulou; Raj S Padwal; Nadia A Khan; Steven A Grover; Daniel G Hackam; Martin G Myers; Donald W McKay; Robert R Quinn; Brenda R Hemmelgarn; Lyne Cloutier; Peter Bolli; Michael D Hill; Thomas Wilson; Brian Penner; Ellen Burgess; Maxime Lamarre-Cliché; Donna McLean; Ernesto L Schiffrin; George Honos; Karen Mann; Guy Tremblay; Alain Milot; Arun Chockalingam; Simon W Rabkin; Martin Dawes; Rhian M Touyz; Kevin D Burns; Marcel Ruzicka; Norman R C Campbell; Michel Vallée; G V Ramesh Prasad; Marcel Lebel; Tavis S Campbell; M Patrice Lindsay; Robert J Herman; Pierre Larochelle; Ross D Feldman; J Malcolm O Arnold; Gordon W Moe; Jonathan G Howlett; Luc Trudeau; Simon L Bacon; Robert J Petrella; Richard Lewanczuk; James A Stone; Denis Drouin; Jean-Martin Boulanger; Mukul Sharma; Pavel Hamet; George Fodor; George K Dresser; S George Carruthers; George Pylypchuk; Richard E Gilbert; Lawrence A Leiter; Charlotte Jones; Richard I Ogilvie; Vincent Woo; Philip A McFarlane; Robert A Hegele; Luc Poirier; Sheldon W Tobe;
Related Documents :
22426035 - Effect of chronic sodium nitrite therapy on monocrotaline-induced pulmonary hypertension.
3458435 - The effects of changes in bite pressure and mucosal stimulation on the perception of ma...
24867405 - The role of dural sinus stenosis in idiopathic intracranial hypertension pathogenesis. ...
24153705 - Iatrogenic air embolism complicating a case of severe septic shock.
19723695 - Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients w...
9227545 - New mechanoenergetic evaluation of left ventricular contractility in in situ rat hearts.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Canadian journal of cardiology     Volume:  27     ISSN:  1916-7075     ISO Abbreviation:  Can J Cardiol     Publication Date:    2011 Jul-Aug
Date Detail:
Created Date:  2011-08-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8510280     Medline TA:  Can J Cardiol     Country:  England    
Other Details:
Languages:  eng     Pagination:  415-433.e2     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
Departments of Medicine, Community Health, and Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Molecular expression of acute phase mediators is attenuated by machine preservation in human liver t...
Next Document:  Efforts to reduce sodium intake in Canada: why, what, and when?